An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy

被引：0

作者：

Sevindik, Omur Gokmen ^{[1
]}

Ozkurt, Zubeyde Nur ^{[2
]}

Boga, Can ^{[3
]}

Besisik, Sevgi Kalayoglu ^{[4
]}

Ipek, Yildiz ^{[5
]}

Geduk, Ayfer ^{[6
]}

Harmandali, Aybuke ^{[7
]}

Salihoglu, Ayse ^{[8
]}

Sahin, Handan Haydaroglu ^{[9
]}

Sonmez, Mehmet ^{[10
]}

Vural, Filiz ^{[11
]}

Akay, Olga Meltem ^{[12
]}

Yuksel, Meltem Kurt ^{[13
]}

Maral, Senem ^{[14
]}

Ekinci, Omer ^{[15
]}

Kirkizlar, Hakki Onur ^{[16
]}

Tekinalp, Atakan ^{[17
]}

Demir, Nazli ^{[18
]}

Merter, Mustafa ^{[15
]}

Saydam, Guray ^{[11
]}

Alacacioglu, Inci ^{[19
]}

Yegin, Zeynep Arzu ^{[2
]}

Kasar, Mutlu ^{[3
]}

Mastanzade, Metban ^{[20
]}

Ozsan, Guner Hayri ^{[19
]}

机构：

[1] Medipol Univ, Istanbul, Turkey

[2] Gazi Univ, Fac Med, Ankara, Turkey

[3] Baskent Univ Hosp, Ankara, Turkey

[4] Istanbul Univ, Div Hematol, Dept Internal Med, Fac Med, Istanbul, Turkey

[5] Dr Lutfi Kartal City Hosp, Istanbul, Turkey

[6] Kocaeli Univ, Fac Med, Izmit, Turkey

[7] Tepecik Educ & Res Hosp, Izmir, Turkey

[8] Istanbul Univ Cerrahpasa, Fac Med, Istanbul, Turkey

[9] Gaziantep Univ, Sahinbey Res & Practice Hosp, Gaziantep, Turkey

[10] Karadeniz Tech Univ, Fac Med, Trabzon, Turkey

[11] Ege Univ, Fac Med, Bornova, Turkey

[12] Koc Univ Hosp, Istanbul, Turkey

[13] Ankara Univ, Fac Med, Ankara, Turkey

[14] Diskapi Yildirim Beyazit Training & Res Hosp, Ankara, Turkey

[15] Firat Univ, Fac Med, Elazig, Turkey

[16] Trakya Univ, Fac Med, Edirne, Turkey

[17] Meram Univ, Fac Med, Konya, Turkey

[18] Istanbul Sisli Hamidiye Etfal Educ & Res Hosp, Istanbul, Turkey

[19] Dokuz Eylul Univ, Fac Med, Alsancak, Turkey

[20] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-125

引用

页码：S102 / S103

页数：2

共 50 条

[31] Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?
Barnes, Chad A.
Krepline, Ashley N.
Aldakkak, Mohammed
Clarke, Callisia N.
Christians, Kathleen K.
Khan, Abdul H.
Hunt, Bryan C.
Ritch, Paul S.
George, Ben
Hall, William A.
Erickson, Beth A.
Evans, Douglas B.
Tsai, Susan
JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 21 (11) : 1793 - 1803
[32] Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?
Chad A. Barnes
Ashley N. Krepline
Mohammed Aldakkak
Callisia N. Clarke
Kathleen K. Christians
Abdul H. Khan
Bryan C. Hunt
Paul S. Ritch
Ben George
William A. Hall
Beth A. Erickson
Douglas B. Evans
Susan Tsai
Journal of Gastrointestinal Surgery, 2017, 21 : 1793 - 1803
[33] Impact of Daratumumab Monotherapy on Bone Metabolism Parameters in Patients with Relapsed and/or Refractory Multiple Myeloma Who Have Received at Least Two Prior Lines of Therapy Including Lenalidomide and a Proteasome Inhibitor: Outcomes of the Phase 2 Rebuild Study
Terpos, Evangelos
Kastritis, Efstathios
Hatjiharissi, Evdoxia
Katodritou, Eirini
Papaiakovou, Evangelos Eleutherakis
Verrou, Evgenia
Gavriatopoulou, Maria
Leonidakis, Alexandros
Ntanasis-Stathopoulos, Ioannis
Delimpasi, Sosana
Kyrtsonis, Marie-Christine
Papaioannou, Maria
Symeonidis, Argiris
Dimopoulos, Meletios A.
BLOOD, 2021, 138
[34] Influence of novel agents on disease progression in patients with multiple myeloma who have received high-dose therapy with stem cell transplantation
Wagner, S.
Munder, M.
Theobald, M.
Hess, G.
ONKOLOGIE, 2012, 35 : 146 - 146
[35] European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy
Tzogani, Kyriaki
Florez, Beatriz
Markey, Greg
Caleno, Mariapaola
Olimpieri, Odoardo Maria
Melchiorri, Daniela
Hovgaard, Doris Johanna
Sarac, Sinan Bardakci
Penttila, Karri
Lapvetelainen, Tuomo
Salmonson, Tomas
Bergh, Jonas
Gisselbrecht, Christian
Pignatti, Francesco
ESMO OPEN, 2019, 4 (05)
[36] The efficacy of salvage autologous stem cell transplant among patients with multiple myeloma who received maintenance therapy post initial transplant
Manjappa, Shivaprasad
Fiala, Mark A.
King, Justin
Kohnen, Daniel A.
Vij, Ravi
BONE MARROW TRANSPLANTATION, 2018, 53 (11) : 1483 - 1486
[37] Long-term follow-up of melanoma patients who have received Allovectin-7 gene therapy treatment
Hersh, E
Klasa, R
Gonzalez, R
Doroshow, J
Weber, J
Cluer, J
Selk, L
CANCER GENE THERAPY, 1999, 6 (06) : S25 - S25
[38] Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy
Amano, Koichi
INTERNAL MEDICINE, 2006, 45 (17) : 991 - 992
[39] The Osteoblastogenesis Potential of Adipose Mesenchymal Stem Cells in Myeloma Patients Who Had Received Intensive Therapy
Lin, Hsiu-Hsia
Hwang, Shiaw-Min
Wu, Shang-Ju
Hsu, Lee-Feng
Liao, Yi-Hua
Sheen, Yi-Shuan
Chuang, Wen-Hui
Huang, Shang-Yi
PLOS ONE, 2014, 9 (04):
[40] ANALYSIS OF THE CONNECT MM REGISTRY: TREATMENT OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA WHO RECEIVED LENALIDOMIDE MAINTENANCE OR NO MAINTENANCE
Rifkin, R. M.
Jagannath, S.
Durie, B. G.
Shah, J. J.
Narang, M.
Terebelo, H. R.
Gasparetto, C. J.
Toomey, K.
Hardin, J. W.
Wagner, L.
Parikh, K.
Abouzaid, S.
Srinivasan, S.
Kitali, A.
Zafar, F.
Abonour, R.
HAEMATOLOGICA, 2017, 102 : 523 - 524

← 1 2 3 4 5 →